drugset / Trial / NCT00349258

The Use of GnRH Agonist Trigger in the Prevention of OHSS

NCT00349258

Phase 4 Completed 66 enrolled University of Connecticut Organon · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the incidence of ovarian hyperstimulation syndrome (OHSS) and implantation rate between high responder patients using Gonadotropin releasing GnRH) agonist or human chorionic gonadotropin (hCG) to trigger final oocyte maturation.

Timeline

Start
2004-08
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Leuprolide Other / unclassified